Muzolimine

This classification denotes an antihypertensive agent and diuretic with the molecular formula C11H11Cl2N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 07Z36289ZX, chemically known as 5-amino-2-(1-(3,4-dichlorophenyl)-ethyl)-2,4-dihydro-3h-pyrazol-3-one but generally known as muzolimine, which bears US NIH Compound Identifier 41386. European Medicines Agency schedules Muzolimine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09097MIG. World Health Organization schedules muzolimine in its Anatomical Therapeutic Chemical (ATC) Classification. MUZOLIMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule muzolimine under HS 29331990 and SITC 51571. As of Q4 2014, MUZOLIMINE remains the US FDA Preferred Term for this commodity. SMILES: CC(C1=CC(=C(C=C1)Cl)Cl)N2C(=O)CC(=N2)N.